HSBC Holdings’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$293K Buy
+7,717
New +$234K ﹤0.01% 2529
2025
Q1
Sell
-30,584
Closed -$1M 3013
2024
Q4
$1M Buy
30,584
+25,752
+533% +$1.21M ﹤0.01% 1798
2024
Q3
$220K Sell
4,832
-1,155
-19% -$52.5K ﹤0.01% 2550
2024
Q2
$261K Sell
5,987
-870
-13% -$31.4K ﹤0.01% 2382
2024
Q1
$200K Buy
+6,857
New +$184K ﹤0.01% 2681
2022
Q3
Sell
-15,424
Closed -$341K 2899
2022
Q2
$341K Buy
15,424
+2,333
+18% +$52.7K ﹤0.01% 2562
2022
Q1
$386K Buy
+13,091
New +$400K ﹤0.01% 2595
2021
Q3
Sell
-3,758
Closed -$209K 2966
2021
Q2
$209K Sell
3,758
-513
-12% -$28.7K ﹤0.01% 2735
2021
Q1
$222K Sell
4,271
-1,685
-28% -$83.4K ﹤0.01% 2489
2020
Q4
$259K Sell
5,956
-422
-7% -$16.7K ﹤0.01% 2664
2020
Q3
$225K Buy
6,378
+993
+18% +$43.5K ﹤0.01% 2400
2020
Q2
$288K Buy
+5,385
New +$249K ﹤0.01% 2150
2020
Q1
Sell
-7,528
Closed -$363K 2666
2019
Q4
$363K Buy
7,528
+457
+6% +$17.3K ﹤0.01% 2414
2019
Q3
$229K Buy
+7,071
New +$293K ﹤0.01% 2791
2015
Q3
Sell
-2,898
Closed -$323K 1928
2015
Q2
$323K Buy
+2,898
New +$312K ﹤0.01% 1575
2015
Q1
Sell
-1,798
Closed -$201K 2044
2014
Q4
$201K Buy
+1,798
New +$161K ﹤0.01% 1700

Other funds holding AGIO

HSBC Holdings's AGIO Position: Q2 2026 in Review

HSBC Holdings opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2026: 7,717 shares worth $293K. The stake represents ﹤0.01% of the portfolio and ranks #2529 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in AGIO as recently as Q4 2024.

HSBC Holdings first reported a position in AGIO in Q4 2014 and has held it in 16 quarters since. The position peaked at $1M in Q4 2024. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • HSBC Holdings held 7,717 shares of Agios Pharmaceuticals worth $293K as of Q2 2026.
  • Agios Pharmaceuticals was a new HSBC Holdings position in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2529 holding.
  • HSBC Holdings first reported a position in Agios Pharmaceuticals in Q4 2014 and has held it in 16 quarters since.
  • HSBC Holdings's Agios Pharmaceuticals position peaked at $1M in Q4 2024.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.